SCHEMBL8279472

SCHEMBL8279472

Cc1ccc(-n2c(CNc3ccc(F)cc3)cnc2S)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.47
ABL1 P00519 1/20 0.47
NTRK1 P04629 1/20 0.47
LCK P06239 1/20 0.47
CSF1R P07333 1/20 0.47
RET P07949 1/20 0.47
MET P08581 1/20 0.47
PDGFRB P09619 1/20 0.47
PIM1 P11309 1/20 0.47
PDGFRA P16234 1/20 0.47
FLT3 P36888 1/20 0.47
MAPK8 P45983 1/20 0.47
CDK8 P49336 1/20 0.47
MAP2K1 Q02750 1/20 0.47
MAP4K2 Q12851 1/20 0.47
ROCK1 Q13464 1/20 0.47
NTRK3 Q16288 1/20 0.47
MAPK14 Q16539 1/20 0.47
AURKB Q96GD4 1/20 0.47
GAA P10253 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404748 0.78 GAA (0.60) AURKAABL1NTRK1LCKCSF1R
SCHEMBL8280432 0.72 CNR1 (0.48) GAAALDH1A1MAPTSMN1; SMN2KMT2A
SCHEMBL3830999 0.72 PTGS2 (0.52) FLT3GAALMNAHTTALDH1A1
SCHEMBL6510547 0.71 PTGS2 (0.39) L3MBTL1HTTALDH1A1SMN1; SMN2KDM4E
SCHEMBL8279473 0.70 SMN1; SMN2 (0.47) GAAL3MBTL1LMNAHTTALDH1A1
SCHEMBL4196789 0.69 ALDH1A1 (0.43) NTRK1GAAL3MBTL1LMNAHTT
SCHEMBL5450663 0.68 GAA (0.77) GAAL3MBTL1LMNAHTTALDH1A1
SCHEMBL6414545 0.67 MAPT (0.67) AURKAABL1NTRK1LCKCSF1R
SCHEMBL171854 0.67 MAPT (0.67) AURKAABL1NTRK1LCKCSF1R
SCHEMBL6404661 0.65 KMT2A (0.51) GAAL3MBTL1LMNAHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070281937-A1 Ion Channel Modulators SCION PHARMACEUTICALS, INC. 2007-12-06 US disclosed
US-20070281937-A1 Ion Channel Modulators SCION PHARMACEUTICALS, INC. 2007-12-06 US disclosed
US-20070208064-A1 Ion channel modulators WYETH (US) 2007-09-06 US disclosed
US-20070208064-A1 Ion channel modulators WYETH (US) 2007-09-06 US disclosed
WO-2005087228-A1 ION CHANNEL MODULATORS WYETH (US) 2005-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281937-A1 Ion Channel Modulators CACNA1B, CACNA1C, TRPV1 AURKA 3177/4885ABL1 3428/4885NTRK1 2427/4885
US-20070208064-A1 Ion channel modulators CACNA1B, CACNA1C, TRPV1 AURKA 3177/4885ABL1 3428/4885NTRK1 2427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.